[go: up one dir, main page]

MA56197A - Procédés d'élimination de composants indésirables pendant des processus chromatographiques en plusieurs étapes - Google Patents

Procédés d'élimination de composants indésirables pendant des processus chromatographiques en plusieurs étapes

Info

Publication number
MA56197A
MA56197A MA056197A MA56197A MA56197A MA 56197 A MA56197 A MA 56197A MA 056197 A MA056197 A MA 056197A MA 56197 A MA56197 A MA 56197A MA 56197 A MA56197 A MA 56197A
Authority
MA
Morocco
Prior art keywords
methods
components during
removing unwanted
unwanted components
during multi
Prior art date
Application number
MA056197A
Other languages
English (en)
Inventor
Mark Chiboroski
Travis Tran
Andrew Tustian
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MA56197A publication Critical patent/MA56197A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
    • B01D15/203—Equilibration or regeneration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MA056197A 2019-06-13 2020-06-12 Procédés d'élimination de composants indésirables pendant des processus chromatographiques en plusieurs étapes MA56197A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962860980P 2019-06-13 2019-06-13

Publications (1)

Publication Number Publication Date
MA56197A true MA56197A (fr) 2022-04-20

Family

ID=71608046

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056197A MA56197A (fr) 2019-06-13 2020-06-12 Procédés d'élimination de composants indésirables pendant des processus chromatographiques en plusieurs étapes

Country Status (13)

Country Link
US (1) US20220306686A1 (fr)
EP (1) EP3983426A1 (fr)
JP (2) JP7653920B2 (fr)
KR (1) KR20220024513A (fr)
CN (1) CN113993879A (fr)
AU (1) AU2020293237A1 (fr)
BR (1) BR112021024417A2 (fr)
CA (1) CA3143024A1 (fr)
EA (1) EA202290040A1 (fr)
IL (1) IL288630A (fr)
MA (1) MA56197A (fr)
MX (1) MX2021015087A (fr)
WO (1) WO2020252260A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022234412A1 (fr) 2021-05-03 2022-11-10 Lupin Limited Procédé de purification de protéines de fusion fc

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex
AU3921993A (en) * 1992-03-18 1993-10-21 Osteosa Inc. Novel antler-derived bone growth factors
WO2005000898A2 (fr) 2003-06-27 2005-01-06 Biogen Idec Ma Inc. Purification et synthese preferentielle de molecules de liaison
WO2006074399A2 (fr) 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Molecules de liaison multispecifiques comprenant des peptides de connexion
PT2193142E (pt) * 2007-08-30 2015-04-22 Curedm Group Holdings Llc Composições e procedimentos de utilização de peptídeos pro-ilhota e seus análogos
MX368932B (es) 2009-06-26 2019-10-22 Regeneron Pharma Anticuerpos biespecificos facilmente aislados con formato de inmunoglobulina original.
EP3041593B1 (fr) 2013-09-05 2025-01-29 F. Hoffmann-La Roche AG Procédé de nettoyage d'un matériau de chromatographie en vue de sa réutilisation
AR101262A1 (es) * 2014-07-26 2016-12-07 Regeneron Pharma Plataforma de purificación para anticuerpos biespecíficos
GB201602156D0 (en) * 2016-02-05 2016-03-23 Jones Philip C And Boku University Of Natural Resources And Life Sciences Heterodimers and purification thereof
CN112771379B (zh) 2018-08-17 2024-07-02 瑞泽恩制药公司 用于测定多聚体蛋白质的量和纯度的方法和色谱系统

Also Published As

Publication number Publication date
EA202290040A1 (ru) 2022-03-05
JP2025102816A (ja) 2025-07-08
CA3143024A1 (fr) 2020-12-17
EP3983426A1 (fr) 2022-04-20
JP7653920B2 (ja) 2025-03-31
BR112021024417A2 (pt) 2022-01-18
MX2021015087A (es) 2022-01-18
KR20220024513A (ko) 2022-03-03
JP2022536470A (ja) 2022-08-17
US20220306686A1 (en) 2022-09-29
IL288630A (en) 2022-02-01
WO2020252260A1 (fr) 2020-12-17
AU2020293237A1 (en) 2022-01-06
CN113993879A (zh) 2022-01-28

Similar Documents

Publication Publication Date Title
EP4198154C0 (fr) Procédé de récupération de métal de valeur
MA54880A (fr) Compositions et procédés de traitement de troubles neurocognitifs
JOP20180014A1 (ar) جسم مضاد متوافق مع البشر لعلاج أو الوقاية من الاضطرابات الإدراكية، وعملية لإنتاجه، وعامل لعلاج أو الوقاية من الاضطرابات الإدراكية باستخدامه
EA201990296A1 (ru) Антитела против siglec-7 для лечения рака
EP4041241A4 (fr) Procédés de traitement de la myélofibrose et d'affections associées
EP3784363A4 (fr) Procédés pour la séparation de composants sanguins
EP3641522A4 (fr) Systèmes automatisés pour prélever des échantillons de tissu de graines, et procédés associés
EP3914235A4 (fr) Procédés de traitement de la dépendance
EP3684488A4 (fr) Procédés de conception d'un procédé de séparation chromatographique préparative efficace
MA55087A (fr) Compositions et procédés de traitement de laminopathies
HK1246810A1 (zh) Lingo-1对抗药及用於治疗脱髓鞘疾病的用途
EP3775171A4 (fr) Procédés de traitement d'un cancer résiduel minimal
EP3463613A4 (fr) Appareil et procédés de filtration de métaux
IL287008A (en) Modified anti-pd-l1 antibodies and methods and uses for treating a neurodegenerative disease
EP3811400A4 (fr) Système et procédé pour processus de traitement par voie humide autonettoyant
EP3863530A4 (fr) Système, procédé et dispositif améliorés de traitement de reflux gastro-oesophagien
MA56197A (fr) Procédés d'élimination de composants indésirables pendant des processus chromatographiques en plusieurs étapes
MA55531A (fr) Procédés pour le traitement de béta-thalassémie
EP3691694A4 (fr) Anticorps monoclonaux d'adn ciblant le ctla-4 pour le traitement et la prévention du cancer
MA41961A (fr) Procédés de régénération d'adsorbants solides
EP4412749A4 (fr) Procédé et système de radiochimie du lu-177
GB201911686D0 (en) Process for purifying target substances
IL308393A (en) Antibodies for the treatment of alpha-synuclein diseases
EP4366867A4 (fr) Produit pour adsorption de métal
IL290770A (en) Compounds and methods for treating oxalate-related diseases